Systemic and central nervous system correction of lysosomal storage in mucopolysaccharidosis type VII mice

Journal of Virology

Volumn 73, Issue 4, 1999, Pages 3424-3429

  Stein, Colleen S ^a   Ghodsi, Abdi ^a   Derksen, Todd ^a   Davidson, Beverly L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY MR 1; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME SYNTHESIS; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; INTRAVENOUS DRUG ADMINISTRATION; LYSOSOME STORAGE DISEASE; MOUSE; MUCOPOLYSACCHARIDOSIS TYPE 7; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE; VIRUS RECOMBINANT;

EID: 0032976576     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.4.3424-3429.1999     Document Type: Article

References (50)

1. Bancroft, J. D. 1982. Enzyme histochemistry, p. 387-388. In J. D. Bancroft and A. Stevens (ed.), Theory and practice of histological techniques. Churchill Livingstone, New York, N.Y.
2. Barr, D., J. Tubb, D. Ferguson, A. Scaria, A. Lieber, C. Wilson, J. Perkins, and M. A. Kay. 1995. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2:151-155.
3. Bastedo, L., M. S. Sands, D. T. Lambert, M. A. Pisa, E. Birkenmeier, and P. L. Chang. 1994. Behavioral consequences of bone marrow transplantation in the treatment of murine mucopolysaccharidosis type VII. J. Clin. Investig. 94:1180-1186.
4. Birkenmeier, E. H., J. E. Barker, C. A. Vogler, J. W. Kyle, W. S. Sly, B. Gwynn, B. Levy, and C. Pegors. 1991. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood 78:3081-3092.
5. Birkenmeier, E. H., M. T. Davisson, W. G. Beamer, R. E. Ganschow, C. A. Vogler, B. Gwynn, K. A. Lyford, L. M. Maltais, and C. J. Wawrzyniak. 1989. Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency. J. Clin. Investig. 83:1258-1256.
6. Byrnes, A. P., R. E. MacLaren, and H. M. Charlton. 1996. Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. J. Neurosci. 16(9):3045-3055.
7. Byrnes, A. P., M. J. A. Wood, and H. M. Charlton. 1996. Role of T cells in inflammation caused by adenovirus vectors in the brain. Gene Ther. 3:644-651.
8. Chillon, M., A. Bosch, J. Zabner, L. Law, D. Armentano, M. J. Welsh, and B. L. Davidson. 1999. Group D adenoviruses infect primary central nervous system cells more efficiently than those from group C. J. Virol. 73:2537-2540.
9. Dai, Y., E. M. Schwarz, D. Gu, W. W. Zhang, N. Sarvetnick, and I. M. Verma. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92:1401-1405.
10. Foy, T. M., J. D. Laman, J. A. Ledbetter, A. Aruffo, E. Claassen, and R. J. Noelle. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:157-163
11. Foy, T. M., D. M. Shepherd, F. H. Durie, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178:1567-1575.
12. Gao, G-P., Y. Yang, and J. M. Wilson. 1996. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol. 70:8934-8943.
13. Ghodsi, A., G. Yang, T. Derksen, C. Stein, R. D. Anderson, and B. L. Davidson. 1998. Extensive β-glucuronidase activity in murine CNS after adenovirus mediated gene transfer to brain. Hum. Gene Ther. 9:2331-2340.
14. Glaser, J. H., and W. S. Sly. 1973. Beta-glucuronidase deficiency mucopolysaccharidosis: methods for enzymatic diagnosis. J. Lab. Clin. Med. 82:969-977.
15. Jooss, K., H. C. Ertle, and J. M. Wilson. 1998. Cytotoxic T-lmphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver. J. Virol. 72:2945-2954.
16. Joss, K., Y. Yang, K. J. Fisher, and J. M. Wilson. 1998. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol. 72:4212-4223.
17. Kay, M. A., L. Meuse, A. M. Gown, P. Linsley, D. Hollenbaugh, A. Aruffo, H. D. Ochs, and C. B. Wilson. 1997. Transient immunomodulation with anti-CD40 ligand antibody and (TLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver. Proc. Natl. Acad. Sci. USA 94:4686-4691.
18. Kozarsky, K. F., K. Joss, M. Donahee, J. F. I. I. I. Strauss, and J. M. Wilson. 1996. Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene. Nat. Genet. 13:54-62.
19. Laman, J. D., E. Claassen, and R. J. Noelle. 1996. Functions of CD40 and its ligand, gp39 (CD40L). Crit. Rev. Immunol. 16:59-108.
20. Li. T., and B. L. Davidson. 1995. Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 92:7700-7704.
21. Marechal, V., N. Naffakh, O. Danos, and J. M. Heard. 1993. Disappearance of lysosomal storage in spleen and liver of mucopolysaccharidosis VII mice after transplantation of genetically modified bone marrow cells. Blood 82: 1358-1365.
22. Morral, N., W. O'Neal, H. Zhou, C. Langston, and A. Beaudet. 1997. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors. Hum. Gene Ther. 8:1275-1286.
23. Mouiller, P., D. Bohl, J.-M. Heard, and O. Danos. 1993 Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts. Nat. Genet. 4:154-159.
24. Neufeld, E. F., and J. Muenzer. 1995. The mucopolysaccharidoses. p. 2465-2494. In C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle (ed.). The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, N.Y.
25. O'Connor, L. H., L. C. Erway, C. A. Vogler, W. S. Sly, A. Nicholes, J. Grubb, S. W. Holmberg, B. Levy, and M. S. Sands. 1998. Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function. J. Clin. Investig. 101:1394-1400.
26. Ohashi, T., K. Watabe, K. Uehara, W. S. Sly, C. Vogler, and Y. Eto. 1997. Adenovirus-mediated gene transfer and expression of human β-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice. Proc. Natl. Acad. Sci. USA 94:1287-1292.
27. Quantin, B., L. D. Perricaudet, S. Tajbakhsh, and J. L. Mandel. 1992 Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl. Acad. Sci. USA 89:2581-2584.
28. Sands, M. S., J. E. Barker, C. Vogler, B. Levy, B. Gwynn, N. Galvin, W. S. Sly, and E. Birkenmeier. 1993. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab. Investig. 68:676-686.
29. Sands, M. S., and E. H. Birkenmeier. 1993. A single-base-pair deletion in the beta-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VII. Proc. Natl. Acad. Sci. USA 90:6567-6571.
30. Sands, M. S., L. C. Erway, C. Vogler, W. S. Sly, and E. H. Birkenmeier. 1995. Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VII. Blood 86:2033-2040.
31. Sands, M. S., C. Vogler, J. W. Kyle, J. H. Grubb, B. Levy, N. Galvin, W. S. Sly, and E. H. Birkenmeier. 1994. Enzyme replacement therapy for murine mucopolysaccharidosis type VII. J. Clin. Investig. 93:2324-2331.
32. Scaria, A., J. A. George, R. J. Gregory, R. J. Noelle, S. C. Wadsworth, A. E. Smith, and J. M. Kaplan. 1997. Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway. Gene Ther. 4:611-617.
33. Schiedner, G., N. Morral, R. J. Parks, Y. Wu, S. C. Koopmans, C. Langston, F. L. Graham, A. L. Beaudet, and S. Kochanek. 1998. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18:1811-183.
34. Sly, W. Personal communication.
35. Snyder, E. Y., R. M. Taylor, and J. H. Wolfe. 1995. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374:367-370.
36. Stein, C. S., J. L. Pemberton, N. van Rooijen, and B. L. Davidson. 1998. Effects of macrophage depletion and anti-CD40 ligand on transgene expression and redosing with recombinant adenovirus. Gene Ther. 5:431-439.
37. Taylor, R. M., and J. H. Wolfe. 1994. Cross-correction of β-glucuronidase deficiency by retroviral vector-mediated gene transfer. Exp. Cell Res. 214: 606-613.
38. Taylor, R. M., and J. H. Wolfe. 1997. Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of β-glucuronidase. Nat. Med. 3:771-774.
39. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2:545-5511.
40. Van den Eertwegh, A. J. M., R. J. Noelle, M. Roy, D. M. Shepherd, A. Aruffo, J. A. Ledbetter, W. J. A. Boersma, and E. Claassen. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. J. Exp. Med. 178:1555-1565.
41. Vogler, C., M. Sands, A. Higgins, B. Levy, J. Grubb, E. H. Birkenmeier, and W. S. Sly. 1993. Enzyme replacement with recombinant β-glucuronidase in the newborn mucopolysaccharidosis type VII. Pediatr. Res. 34:837-840.
42. Wadsworth, S. C., H. Zhou, A. E. Smith, and J. M. Kaplan. 1997. Adenovirus vector-infected cells can escape adenovirus antigen-specific cytotoxic T-lymphocyte killing in vivo. J. Virol. 71:5189-5196.
43. Wilson. C. B., L. J. Embree, D. Schowalter, R. Albert, A. Aruffo, D. Hollenbaugh, P. Linsley, and M. A. Kay. 1998. Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administration. J. Virol. 72:7542-7550.
44. Wolfe, J. H., S. L. Deshmane, and N. W. Fraser. 1992. Herpesvirus vector gene transfer and expression of beta-glucuronidase in the central nervous system of MPS VII mice. Nat. Genet. 1:379-384.
45. Wolfe, J. H., M. S. Sands, J. E. Barker, B. Gwynn, L. B. Rowe, C. A. Vogler, and E. H. Birkenmeier. 1992. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer. Nature 360:749-753.
46. Yang, Y., H. C. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442.
47. Yang, Y., Q. Li, H. C. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
48. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
49. Yang, Y., Q. Su, I. S. Grewal, R. Schilz, R. A. Flavell, and J. M. Wilson. 1996. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J. Virol. 70:6370-6377.
50. Yao, S. N., A. Farjo, B. J. Roessler, B. L. Davidson, and K. Kurachi. 1996. Adenovirus-mediated transfer of human factor IX gene in immunodeficient and normal mice: evidence for prolonged stability and activity ot the transgene in liver. Viral Immunol. 9:141-153.